Fibrate treatment induced quantitative and qualitative HDL changes associated with an increase of SR-BI cholesterol efflux capacities in rabbits

Biochimie

Volumn 95, Issue 6, 2013, Pages 1278-1287

  Fournier, Natalie ^a,b   Tuloup Minguez, Véronique ^a   Pourci, Marie Luce ^a,c   Thérond, Patrice ^c   Jullian, Jean Christophe ^d   Wien, Frank ^e   Leroy, Michel ^f   Dallongeville, Jean ^g   Paul, Jean Louis ^a,b   Leroy, Arnaud ^a  

^a EA 4529   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c BICÊTRE HOSPITAL   (France)

^d CNRS   (France)

^e SYNCHROTRON SOLEIL   (France)

^f INSTRULABO   (France)

^g INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Fatty acid profiles and phospholipid species; Fenofibrate; HDL structure; LCAT; SR BI cholesterol efflux

Indexed keywords

APOLIPOPROTEIN A1; ESTER; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; SCAVENGER RECEPTOR BI; SPHINGOMYELIN;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; RABBIT;

ANIMALS; CHOLESTEROL; CIRCULAR DICHROISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FENOFIBRATE; HYPOLIPIDEMIC AGENTS; ISOELECTRIC FOCUSING; LIPOPROTEINS, HDL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RABBITS;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 84877724974     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.02.001     Document Type: Article

References (58)

1. B. Staels, and J. Auwerx Role of PPAR in the pharmacological regulation of lipoprotein metabolism by fibrates and thiazolidinediones Curr. Pharmaceutical. Des. 3 1997 1 14 (Pubitemid 27215884)
2. A. Shah, D.J. Rader, and J.S. Millar The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans Atherosclerosis 210 2010 35 40
3. R.S. Rosenson Fenofibrate: treatment of hyperlipidemia and beyond Expert Rev. Cardiovasc. Ther. 6 2008 1319 1330
4. B. Staels, and J. Auwerx Regulation of apo A-I gene expression by fibrates Atherosclerosis 137 Suppl 1998 S19 S23 (Pubitemid 28294203)
5. B. Staels, J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, and J.C. Fruchart Mechanism of action of fibrates on lipid and lipoprotein metabolism Circulation 98 1998 2088 2093 (Pubitemid 28512236)
6. N. Vu-Dac, K. Schoonjans, B. Laine, J.C. Fruchart, J. Auwerx, and B. Staels Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element J. Biol. Chem. 269 1994 31012 31018 (Pubitemid 24377592)
7. B. Staels, A. van Tol, T. Andreu, and J. Auwerx Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat Arterioscler. Thromb. 12 1992 286 294
8. N. Hennuyer, P. Poulain, L. Madsen, R.K. Berge, L.M. Houdebine, D. Branellec, J.C. Fruchart, C. Fiévet, N. Duverger, and B. Staels Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response Circulation 99 1999 2445 2451 (Pubitemid 29218242)
9. J.M. Chapman Comparative analysis of mammalian plasma species Methods Enzymol. 128 1986 70 143
10. T. Tsukada, M. Rosenfeld, R. Ross, and A.M. Gown Immunocytochemical analysis of cellular components in atherosclerotic lesions, Use of monoclonal antibodies with the Watanabe and fat-fed rabbit Arteriosclerosis 6 1986 601 613 (Pubitemid 17190161)
11. A.V. Khera, M. Cuchel, M. de la Llera Moya, A. Rodrigues, M.F. Burke, K. Jafri, B.C. French, J.A. Philips, M.L. Mucksavage, R.L. Wilenski, E.R. Mohler, G.H. Rothblat, and D.J. Rader Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N. Engl. J. Med. 364 2011 127 135
12. J. Becart, C. Chevalier, and J.P. Biesse Oxidative analysis of phospholipids by HPLC with a light scattering evaporating detector; application to raw materials for cosmetic use J. High Resolution Chromatogr. 13 1990 126 129
13. N. Fournier, J.L. Paul, V. Atger, A. Cogny, T. Soni, M. de la Llera-Moya, G. Rothblat, and N. Moatti HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum Arterioscler. Thromb. Vasc. Biol. 17 1997 2685 2691 (Pubitemid 28016009)
14. J. Picard, D. Veissiere, F. Voyer, and G. Bereziat Phospholipids of cholestasis. Abnormal lipoproteins of fatty acid composition Clin. Chim. Acta 36 1972 247 250
15. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophages T4 Nature 227 1970 680 685
16. D.L. Sparks, and M.C. Phillips Quantitative measurement of lipoprotein surface charge by agarose gel electrophoresis J. Lipid Res. 33 1992 123 130
17. A. Leroy, K.L.H. Toohill, J.C. Fruchart, and A. Jonas Structural properties of high density lipoprotein subclasses homogeneous in protein composition and in size J. Biol. Chem. 268 1993 4798 4805 (Pubitemid 23081596)
18. A. Leroy, and A. Jonas Native like structure and self association behavior of apolipoprotein A-I in a Water/n-propanol solution Biochem. Biophys. Acta 1212 1994 285 294 (Pubitemid 24181670)
19. N. Fournier, V. Atger, J.L. Paul, M. de la Llera Moya, G. Rothblat, and N. Moatti Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes Atherosclerosis 147 1999 227 235 (Pubitemid 29512253)
20. C.H. Chen, and J.J. Albers Characterization of proteoliposomes containing apoprotein A-I: A new substrate for the measurement of lecithin: cholesterol acyltransferase activity J. Lipid Res. 23 1982 680 691 (Pubitemid 13227199)
21. M. de la Llera Moya, V. Atger, J.L. Paul, N. Fournier, N. Moatti, P. Giral, K.E. Friday, and G. Rothblat A cell culture system for screening human serum for ability to promote cellular cholesterol efflux: relations between serum components and efflux, esterification, and transfer Arterioscl. Thromb. 14 1994 1056 1065
22. S. Mweva, J.L. Paul, M. Cambillau, D. Goudouneche, P. Beaune, A. Simon, and N. Fournier Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacity Eur. J. Clin. Invest. 36 2006 552 559 (Pubitemid 44086770)
23. G.L. Peterson A simplification of the protein assay method of Lowry et al. which is more generally applicable Anal. Biochem. 83 1977 346 356 (Pubitemid 8269786)
24. A.L. Borresen High density lipoprotein (HDL) polymorphisms in rabbit. A comparative study of rabbit and human serum high density lipoprotein J. Immunogenet. 3 1976 73 81
25. E. Jeanpierre, T. Le Tourneau, C. Zawadzki, E. Van Belle, F. Mouquet, S. Susen, M.D. Ezekowitz, B. Staels, B. Jude, and D. Corseaux Beneficial effects of fenofibrate on plaque thrombogenicity and plaque stability in atherosclerotic rabbits Cardiovasc. Pathol. 18 2009 140 147
26. T. Matsuzaka, H. Shimano, N. Yahagi, M. Amemiya-Kudo, T. Yoshikawa, A.H. Hasty, Y. Tamura, J. Osuga, H. Okazaki, Y. Iizuka, A. Takahashi, H. Sone, T. Gotoda, S. Ishibashi, and N. Yamada Dual regulation of mouse Delta(5)- and Delta(6) desaturase gene expression by SREBP-1 and PPARalpha J. Lipid Res. 43 2002 107 114 (Pubitemid 34117224)
27. Y. Kawashima, K. Musoh, and H. Kozuka Peroxisome proliferators enhance linoleic acid metabolism in rat liver. Increased biosynthesis of omega 6 polyunsaturated fatty acids J. Biol. Chem. 265 1990 9170 9175
28. W.S. Davidson, D.L. Sparks, S. Lund-Katz, and M.C. Philipps The molecular basis for the difference in charge between pre-beta and alpha-migrating high density lipoproteins J. Biol. Chem. 269 1994 8959 8965
29. L. Yetukuri, I. Huopaniemi, A. Koivuniemi, M. Maranghi, A. Hiukka, H. Nygren, S. Kaski, M.R. Taskinen, I. Vattulainen, M. Jauhiainen, and M. Orešič High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy PLoS One 6 2011 e23589
30. J.D. Otvos, E.J. Jeyarajah, D.W. Bennett, and R.M. Krauss Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement Clin. Chem. 38 1992 1632 1638
31. H.J. Pownall, Q. Pao, and J.B. Massey Acyl chain and headgroup specificity of human plasma lecithin:cholesterol acyltransferase. Separation of matrix and molecular specificities J. Biol. Chem. 260 1985 2146 2152 (Pubitemid 15105707)
32. J.S. Parks, T.Y. Thuren, and J.D. Schmitt Inhibition of Lecithin:cholesterol acyltransferase activity by synthetic phosphatidylcholine species containing eicosapentaenoic acid or docosahexaenoic acid in the sn-2 position J. Lipid Res. 33 1992 879 887
33. P.J. Barter, G.J. Hopkins, L. Gorjatschko, and M.E. Jones Competitive inhibition of plasma cholesterol esterification by human high-density lipoprotein-subfraction 2 Biochim. Biophys. Acta 793 1984 260 268 (Pubitemid 14136765)
34. P.V. Subbaiah, and M. Liu Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction J. Biol. Chem. 268 1993 20156 20163 (Pubitemid 23278915)
35. K.A. Rye, N.J. Hime, and P.J. Barter The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins J. Biol. Chem. 271 1996 4243 4250
36. D.J. Bolin, and A. Jonas Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding J. Biol. Chem. 271 1996 19152 19158 (Pubitemid 26271578)
37. P.V. Subbaiah, X.C. Jiang, N.A. Belikova, B. Aizezi, Z.H. Huang, and C.A. Reardon Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity Biochim. Biophys. Acta 1821 2012 908 913
38. J.W. Burgess, J. Boucher, T.A. Neville, P. Rouillard, C. Stamler, S. Zachariah, and D.L. Sparks Phosphatidylinositol promotes cholesterol transport and excretion J. Lipid Res. 44 2003 1355 1363 (Pubitemid 37279617)
39. D.L. Sparks, P.G. Frank, and T.A. Neville Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin:cholesterol acyltransferase activity Biochim. Biophys. Acta 1390 1998 160 172 (Pubitemid 28122334)
40. N. Fournier, M. de la Llera Moya, B.F. Burkey, J.B. Swaney, J. Paterniti, N. Moatti, V. Atger, and G.H. Rothblat Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apo A-I transgenic rats J. Lipid Res. 37 1996 1704 1711 (Pubitemid 26275381)
41. N. Fournier, V. Atger, A. Cogny, B. Vedie, P. Giral, A. Simon, N. Moatti, and J. L Paul Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system Atherosclerosis 157 2001 315 323 (Pubitemid 32710010)
42. B. Jian, M. de la Llera-Moya, Y. Ji, N. Wang, M.C. Phillips, J.B. Swaney, A.R. Tall, and G.H. Rothblat Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors J. Biol. Chem. 273 1998 5599 5606 (Pubitemid 28124029)
43. P.G. Yancey, M. de la Llera-Moya, S. Swarnakar, P. Monzo, S.M. Klein, M.A. Connelly, W.J. Johnson, D.L. Williams, and G.H. Rothblat High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI J. Biol. Chem. 275 2000 36596 36604 (Pubitemid 32002059)
44. W.S. Davidson, W.V. Rodrigueza, S. Lund-Katz, W.J. Johnson, G.H. Rothblat, and M.C. Phillips Effects of acceptor particle size on the efflux of cellular free cholesterol J. Biol. Chem. 270 1995 17106 17113
45. P. Marmillot, S. Patel, and M.R. Lakshman Reverse cholesterol transport is regulated by varying fatty acyl chain saturation and sphingomyelin content in reconstituted high-density lipoproteins Metabolism 56 2007 251 259 (Pubitemid 46074073)
46. P. Marmillot, J. Munoz, S. Patel, M. Garige, R.B. Rosse, and M.R. Lakshman Long-term ethanol consumption impairs reverse cholesterol transport function of high-density lipoproteins by depleting high-density lipoprotein sphingomyelin both in rats and in humans Metabolism 56 2007 947 953 (Pubitemid 46890978)
47. W.S. Davidson, K.L. Gillotte, S. Lund-Katz, W.J. Johnson, G.H. Rothblat, and M.C. Phillips The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol J. Biol. Chem. 270 1995 5882 5890
48. M. Guha, D.L. Gantz, and O. Gursky Effects of acyl chain length, unsaturation, and pH on thermal stability of model discoidal HDLs J. Lipid Res. 49 2008 1752 1761
49. M. Guerin, W. Le Goff, E. Frisdal, S. Schneider, D. Milosavljevic, E. Bruckert, and M.J. Chapman Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux J. Clin. Endocrinol. Metab. 88 2003 3738 3746 (Pubitemid 37034522)
50. A.R. Tall Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins J. Intern. Med. 263 2008 256 273 (Pubitemid 351207349)
51. J.F. Oram, and R.M. Lawn ABCA1, the gatekeeper for eliminating excess tissue cholesterol J. Lipid. Res. 42 2001 1173 1179 (Pubitemid 32744239)
52. M. Maranghi, A. Hiukka, R. Badeau, J. Sundvall, M. Jauhiainen, and M.R. Taskinen Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: A FIELD substudy Atherosclerosis 219 2011 259 265
53. G. Franceschini, L. Calabresi, C. Colombo, E. Favari, F. Bernini, and C.R. Sirtori Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients Atherosclerosis 192 2007 385 391 (Pubitemid 350087947)
54. G. Chinetti, F. Gbaguidi, S. Griglio, Z. Mallat, M. Antonucci, P. Poulain, J. Chapman, J.C. Fruchart, A. Tedgui, J. Najib-Fruchart, and B. Staels CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors Circulation 101 2000 2411 2417 (Pubitemid 30329133)
55. X. Wang, H.L. Collins, M. Ranalletta, I.V. Fuki, J.T. Billheimer, G.H. Rothblat, A.R. Tall, and D.J. Rader Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo J. Clin. Invest. 117 2007 2216 2224 (Pubitemid 47219566)
56. S. Larrede, C.M. Quinn, W. Jessup, E. Frisdal, M. Olivier, V. Hsieh, M.J. Kim, M. Van Eck, P. Couvert, A. Carrie, P. Giral, M.J. Chapman, M. Guerin, and W. Le Goff Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent Arterioscler. Thromb. Vasc. Biol. 29 2009 1930 1936
57. N. Rotllan, G. Llaverías, J. Julve, M. Jauhiainen, L. Calpe-Berdiel, C. Hernández, R. Simó, F. Blanco-Vaca, and J.C. Escolà-Gil Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo Biochim. Biophys. Acta 1811 2011 104 110
58. K. Nakaya, J. Tohyama, S.U. Naik, H. Tanigawa, M. Jaye, C. Macphee, J.T. Billheimer, and D.J. Rader Peroxisome proliferator activated receptor-{alpha} activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway Arterioscler. Thromb. Vasc. Biol. 31 2011 1276 1282